MedTrace Logo

Magnesium Sulphate in Perinatal Asphyxia

NCT00553072 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-10-14

No results posted yet for this study

Summary

Magnesium sulphate has been shown to be neuroprotective. The investigators hypothesize that magnesium sulphate infusion given to babies with perinatal asphyxia should improve outcome in the immediate neonatal period.

Conditions

  • Perinatal Asphyxia , Moderate to Severe HIE

Interventions

DRUG

Magnesium sulphate

250 mg/kg/dose in 1 ml normal saline

DRUG

Normal saline

1 ml/kg/dose

Sponsors & Collaborators

  • Sheri Kashmir Institute of Medical Sciences

    lead OTHER

Principal Investigators

  • Dr.Mushtaq A Bhat, M.D. · SKIMS

  • Dr.Javeed I Bhat, M.D. · SKIMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Hour
Max Age
6 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2006-08-31
Completion
2006-08-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00553072 on ClinicalTrials.gov